[1] Selivanova OM, Grishin SY, Glyakina AV, Sadgyan AS, Usha- kova NI, Galzitskaya OV. Analysis of Insulin Analogs and the Strategy of Their Further Development. Biochemistry (Mosc). 2018;83(Suppl 1):S146-S162. doi:10.1134/S0006297918140122.
[2] Johnson, I. S. (1983) Human insulin from recombinant DNA technology, Science, 219, 632-637.
[3] 人体“基因剪刀”抗癌临床试验首次在美国通过审查．人 民网 .
[4] Khan FA, Pandupuspitasari NS, Chun-Jie H, et al. CRISPR/ Cas9 therapeutics: a cure for cancer and other genetic diseases. Oncotarget. 2016 Aug;7(32):52541-52552. DOI: 10.18632/onco- target.9646.
[5] Thakore PI, D’Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA. Highly spe- cific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nature methods. 2015;12:1143–49.
[9] Lundstrom K. RNA Viruses as Tools in Gene Therapy and Vac- cine Development. Genes (Basel). 2019;10(3):189. Published 2019 Mar 1. doi:10.3390/genes10030189.
